Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.
about
Progress and problems in understanding and managing primary Epstein-Barr virus infectionsOn the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosisPhase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisFluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.Heterologous immunity between virusesCross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosisHeterologous immunity: immunopathology, autoimmunity and protection during viral infections.Role for early-differentiated natural killer cells in infectious mononucleosisPlasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya.Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infectionSymptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response.Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students.Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control?Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region.Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimensInfectious mononucleosis-like syndrome with high lymphocytosis and positive IgM EBV and CMV antibodies in a three-year-old girl.Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases.Comprehensive assessment of peripheral blood TCRβ repertoire in infectious mononucleosis and chronic active EBV infection patients.A genetic basis for infectious mononucleosis: evidence from a family study of hospitalized cases in Denmark.Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients.Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.Epstein-Barr virus and infectious mononucleosis: what students can teach us.(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection.
P2860
Q24597706-CD1F230B-F3F5-4AD7-8608-43C610CE51E4Q24645207-0169CBF8-1454-4076-BDF8-BF66E24F4029Q24657081-1A1E6D15-96B0-46E2-AD76-D95109E051F0Q33634792-9BD2C339-A0B0-4CB1-90DC-F17915CBE670Q34051846-238CAF46-C7CD-4C0C-85B2-77414B1163CFQ34147153-4D23F2E0-D7E0-472E-BC56-3FE23D796025Q34159981-9A40113C-2C66-480B-B887-40DBA8181154Q34353708-E809F8D2-3C7A-4207-8A47-7D6859135A0AQ34749431-6EEB8CBD-A453-4FF7-9300-CFB1B077422EQ35223805-72CB35EB-9C75-4B84-AD3E-B68E456AA880Q36014520-8D2D9D9F-F24B-4DA8-BD6C-7D1BD77ABF68Q36099296-FAC51BEA-7C08-4566-B86A-C8D73256790AQ36471071-F40E4C4A-DFA6-4C39-B29A-5CD913778C8AQ36528984-05D1EB09-AC43-43FD-9E50-92636BAE6755Q36688962-C8202648-F0A0-47A6-A3B1-602E6A8D968FQ37146126-54424348-B64C-4CFD-ADDB-1CA202695494Q38045798-0DC087AD-D807-4625-B200-B898FD081E03Q39694961-4B0D3C15-E4BC-4FA8-B069-A3FC3D882EB4Q40061975-9BC95A83-F26F-4670-8974-7B438C854174Q40073024-A0CB14BD-FBA8-4C8E-A2C4-04CE06FF5065Q40370488-3D365201-3BFC-4CB6-8E18-59E0E2A601E7Q42220849-7164FA8B-F5E8-46A1-ABDF-C0C0907D62CDQ43065304-4ECCA55F-A13D-4E69-BC69-2D3E061D95C5Q43489588-8C96B529-E88D-43EB-9B8C-8F43AE53BC98Q44061780-84783246-D8AB-4AEF-AE32-44D6380D92D5Q45354141-53A27F99-D9CF-4833-8EC6-620283AEC41DQ45358050-D5318F19-02DC-40EC-895B-208C50A22CB5Q55057118-422289B2-54D2-4E85-9B39-14735F3FC488
P2860
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Asymptomatic primary Epstein-B ...... levels of systemic viral load.
@en
Asymptomatic primary Epstein-B ...... levels of systemic viral load.
@nl
type
label
Asymptomatic primary Epstein-B ...... levels of systemic viral load.
@en
Asymptomatic primary Epstein-B ...... levels of systemic viral load.
@nl
prefLabel
Asymptomatic primary Epstein-B ...... levels of systemic viral load.
@en
Asymptomatic primary Epstein-B ...... levels of systemic viral load.
@nl
P2093
P1433
P1476
Asymptomatic primary Epstein-B ...... levels of systemic viral load.
@en
P2093
Bharadwaj M
Elliott SL
Morrison LE
Sherritt MA
Silleri JM
P304
P356
10.1182/BLOOD.V98.13.3739
P407
P50
P577
2001-12-01T00:00:00Z